Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.
about
Comorbidities and Metabolic Derangement of NAFLDObesity and insulin resistance: an abridged molecular correlationApolipoprotein A-V dependent modulation of plasma triacylglycerol: a puzzlementChanges in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob miceA cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workersShear wave dispersion measures liver steatosis.Bariatric Surgery and Liver TransplantationInhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilizationEffect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastasesSteatosis and steatohepatitis in postmortem material from Northwestern GreeceLiver-specific expression of transcriptionally active SREBP-1c is associated with fatty liver and increased visceral fat mass.Preventing phosphorylation of sterol regulatory element-binding protein 1a by MAP-kinases protects mice from fatty liver and visceral obesity.Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline.The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis.Intrahepatic natural killer T cell populations are increased in human hepatic steatosisMR quantitative biomarkers of non-alcoholic fatty liver disease: technical evolutions and future trends.Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome.The genetic architecture of NAFLD among inbred strains of miceQuantitative Three-Dimensional Imaging of Lipid, Protein, and Water Contents via X-Ray Phase-Contrast Tomography.Associations between Methylenetetrahydrofolate Reductase (MTHFR) Polymorphisms and Non-Alcoholic Fatty Liver Disease (NAFLD) Risk: A Meta-Analysis.Role of pentoxifylline in non-alcoholic fatty liver disease in high-fat diet-induced obesity in mice.Coexistence of hyperlipidemia and acute cerebral ischemia/reperfusion induces severe liver damage in a rat model.Detection of carcinogenic etheno-DNA adducts in children and adolescents with non-alcoholic steatohepatitis (NASH).Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.Plasmatic higher levels of homocysteine in non-alcoholic fatty liver disease (NAFLD)Mice deficient in glycerol-3-phosphate acyltransferase-1 have a reduced susceptibility to liver cancerNon alcoholic fatty liver disease and metabolic syndrome.Zerumbone, a Natural Cyclic Sesquiterpene of Zingiber zerumbet Smith, Attenuates Nonalcoholic Fatty Liver Disease in Hamsters Fed on High-Fat DietMTP -493G/T gene polymorphism is associated with steatosis in hepatitis C-infected patients.Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia.Clinical approaches to non-alcoholic fatty liver diseaseAnalysis of risk factors and their interactions in type 2 diabetes mellitus: A cross-sectional survey in Guilin, China.Roles of liver innate immune cells in nonalcoholic fatty liver disease.Genetic and hormonal control of hepatic steatosis in female and male mice.Core domain mutant Y220C of p53 protein has a key role in copper homeostasis in case of free fatty acids overload.Mechanistic basis of hypermethioninemia.Inhibitory effect of schisandrin B on free fatty acid-induced steatosis in L-02 cells.PNPLA3 rs1010023 Predisposes Chronic Hepatitis B to Hepatic Steatosis but Improves Insulin Resistance and Glucose Metabolism.Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients.Hepatic angiogenesis and fibrosis are common features in morbidly obese patients.
P2860
Q26777147-555C9015-AD45-4B11-B79F-E5B876131517Q26825473-D6D58A96-184C-4984-BBB1-889DE3C8385BQ28256394-3AD8CB9F-FE4F-4DF4-A33B-3B8937CB94BDQ28476015-E4D54982-BD06-46E0-826F-526C024C6E45Q28729949-B7A56ED3-404B-4331-973F-2B1C9B2DBBE8Q30458811-5577F107-921B-463B-9399-94A20783FC05Q33711409-BAD27E1B-8C07-44EF-8C83-EA222B28376EQ33824907-3FA293AC-FE13-4736-ACF4-2AF9C3285529Q33840207-80D242CE-2A20-4F47-9A6F-12DA7CF39D35Q34073625-7C839A14-1C86-4767-9BA8-3CA06DCA73CDQ34171384-CF8375E9-E2C2-4154-83C5-81874EA5E78CQ34182797-4FDCB7DA-2575-4FFE-A4D6-60EDFF6C2F73Q34329644-21AEF064-6285-4F79-9738-13A816739EBDQ34389714-D9354EEF-9DC1-46F9-914F-AC90714AD645Q34772032-C24F8FC4-1714-411C-AC27-81658AF6A0FBQ34990725-B9B451C9-8A9F-4BF9-9131-AEBB64C47A19Q35819589-11D3C899-805D-4238-B3C8-4F4737BE7567Q35825098-13AE8ECE-9E08-4CC2-8335-7ACB4F14B01AQ35966131-837FF38A-9899-48F6-AE29-D5FDB15248F4Q36003451-4F096BDB-1125-45A3-8980-F91F3C53205EQ36209355-E4204A76-3077-4636-9530-A0AA8D2958A5Q36248214-60DFD9A8-7A47-4DE5-9D44-D7125D79E7FDQ36400019-A92B07B7-4010-40B0-A08F-A6E1CBD8CBA0Q36505119-B9FE3C7E-CC44-4092-B66B-4BC1FB430A39Q36766775-764611C2-ED87-4037-B586-FFEDF8C4899FQ36806323-16DFA650-D0E6-4B6B-A3C8-F58CA4C9653AQ37078311-E1827C58-64F9-49E3-80EB-363ADB50023FQ37260526-5D4A3FAB-B48B-4E82-BDB0-CE050E00D35EQ37370730-4E52B5D6-BD84-44B8-AE05-5EA90CAB1CDDQ37397018-7BC707F8-AFB3-45E1-8C7D-0F68D7D40508Q37596187-952F6B49-DB37-4EB8-B462-B7D586507296Q37677869-4FF5E16E-0D9B-4612-BE0E-D2E6FD15B233Q37793003-0C67CE99-C9B1-49D4-9DDC-E6E5FED26FB8Q38798845-08999271-3384-42CD-90BA-CBF43D2D8510Q38830190-0B984FC7-67F1-4D04-A0D5-7EC477201FDFQ38910593-83AE8B86-CC86-4DCC-A6F7-AEB5D4C82E9EQ39531917-489C8256-BCC2-46B8-84FB-62AE5916A145Q40140442-07A7C1A0-5300-419C-9BE1-6F784554DF05Q40893622-2AA4FA99-E231-4D28-9206-77422C8ECB7DQ41872219-71150388-C3F0-466F-B04D-F2228AE1E379
P2860
Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nonalcoholic fatty liver disea ...... esis, diagnosis and treatment.
@en
Nonalcoholic fatty liver disea ...... esis, diagnosis and treatment.
@nl
type
label
Nonalcoholic fatty liver disea ...... esis, diagnosis and treatment.
@en
Nonalcoholic fatty liver disea ...... esis, diagnosis and treatment.
@nl
prefLabel
Nonalcoholic fatty liver disea ...... esis, diagnosis and treatment.
@en
Nonalcoholic fatty liver disea ...... esis, diagnosis and treatment.
@nl
P2093
P2860
P356
P1476
Nonalcoholic fatty liver disea ...... esis, diagnosis and treatment.
@en
P2093
Bart J Verwer
Carin M J van Nieuwkerk
Chris J J Mulder
Tim C M A Schreuder
P2860
P304
P356
10.3748/WJG.14.2474
P407
P577
2008-04-01T00:00:00Z